ANTIBIOTIC SUSCEPTIBILITY PATTERN OF PSEUDOMONAS AERUGINOSA ISOLATED FROM NOSOCOMIAL INFECTIONS IN A TERTIARY CARE HOSPITAL
Main Article Content
Keywords
.
Abstract
INTRODUTION: Pseudomonas aeruginosa is an opportunistic, non-fermenting Gram-negative bacillus that has become a leading cause of healthcare-associated (nosocomial) infections worldwide, especially in critically ill and immunocompromised patients. the present study was designed to evaluate the antibiotic susceptibility pattern of P. aeruginosa isolated from nosocomial infections in a tertiary care hospital.
METHODS: This cross-sectional study was done in the Department of Microbiology, Index Medical College, Hospital and Research Centre, M.U. Indore MP. 300 samples from patients of all age group and both sexes were enrolled in the study. All isolates of Pseudomonas aeruginosa from a variety of clinical specimens, including pus, urine, burn wounds, sputum, bodily fluids, CSF, tracheal secretions, and patient devices were included in the study. The isolates were identified by colony morphology, Gram’s staining and biochemical test according to standard laboratory test methods. In accordance with CLSI 2025 guidelines, each isolate was subjected to an AST using the Kirby-Bauer disc diffusion method.
RESULTS: Out of 300 patients, 225 (75%) were male and 75 (25%) were female. Most commonly affected age group was 46-60 years (30%), followed by 61-75years (24.7%). Pseudomonas aeruginosa was most commonly isolated from pus samples (39.7%) followed by sputum sample (32.3%), urine sample (10.3%). Pseudomonas aeruginosa isolates were 100% susceptible to colistin and polymyxin B. 94.7% isolates were susceptible to imipenem and meropenem. 87.3% isolates were susceptible to piperacillin tazobactam. 81.7% isolates were susceptible to amikacin. 75.7% isolates were susceptible to ciprofloxacin. 73.7% isolates were susceptible to gentamicin. 70.3% isolates were susceptible to netilmicin. 63.3% isolates were susceptible to carbenicillin. 52% isolates were susceptible to aztreonam. Only 33.4% isolates were susceptible to ceftazidime.
CONCLUSION: The study provides updated, hospital-specific antibiotic susceptibility data that can assist clinicians in selecting appropriate empirical and targeted therapy for Pseudomonas aeruginosa infections.
References
Topley. & Wilson. (2006). Microbiology and Microbial infections. 10th edition. Pseudomonas. 690
Unhas JournPang Z, Raudonis R, Glick B R, Lin T-J, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37:177-192. doi:10.1016/j.biotechadv.2018.11.013.
“Antimicrobial resistance in clinical patterns of Pseudomonas aeruginosa.” J Med Sci. 2012
Esfahani SNM, et al. Antibiotic Susceptibility Pattern of Nosocomial and Community-Acquired Pseudomonas aeruginosa in Isfahan: A Prospective Multicenter Study. J Kerman Univ Med Sci. 2024.
Javiya VA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol. 2008;40(5):230–4. [PubMed ID: 20040963].
Harris AD, Jackson SS, Robinson G, et al. Pseudomonas aeruginosa colonisation in the ICU: prevalence, risk factors and clinical outcomes. Infect Control Hosp Epidemiol 2016;37(5):544-548.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 35th ed. M100-ED35. Clinical and Laboratory Standards Institute, Wayne, PA, 2025.
Chastre J, Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000;15:287-98.
Obritsch MD, Fish DN, McLaren R, Jung R. National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa isolates obtained from Intensive Care Unit Patients from 1993 to 2002. Antimicrob Agents Chem 2004;48:4606-10.
Javiya VA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol 2008;4.
Raakhee T, Rao US. prevancen and Resistance pattern of Pseudomonas strains isolated from ICU patients. Int J Curr Microbiol Appl Sci. 2014;3(3):527–34.
Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteraemia:a population based study. Am J Med. 2008;121:702–8.
Khan JA, Iqbal Z, Rahman SU, Ferzana K, Khan A. Report:prevalence and Resistance pattern of Pseudomonas aeruginosa against various antibiotics. Pak J Pharm Sci. 2008;21:311–5.
Araujo WL, Angellis DA, Azevedo JL. Direct RAPD evaluation of bacteria without conventional DNA extraction. Braz Arch Biol Technol. 2004;47(3):375-80.
Wolska K, Kot B, Jakubczak A. Phenotypic and genotypic diversity of Pseudomonas aeruginosa strains isolated from hospitals in siedlce (Poland). Braz J Microbiol. 2012; 274-82.
Ahmed SM, Zakridettu RP, Kottakutty S, Arya B, Shakir VPA. An Emerging multi-drug resistant pathogen in a tertiary care center in North Kerala. Ann Biol Res. 2012;3:2794–99.
Pramodhini S, Umadevi S, Seetha KS. Detection of Virulence determinant and its association with drug resistance in clinical isolates of Pseudomonas aeruginosa . Int J Res Med Sci. 2016;4(9):3917–23.
Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control and Hospital Epidemiology. 2008;29(11):996–1011.
Ramakrishnan K, Rajagopalan S, Nair S, Kenchappa P, Chandrakesan SD. Molecular characterization of metallo β-lactamase producing multidrug resistant Pseudomonas aeruginosa from various clinical samples . Indian J Pathol Microbiol. 2014; 57:579-82.
Vahdani M, Azimi L, Asghari B, Bazmi F, Rastegar Lari A. Phenotypic screening of extended-spectrum β-lactamase and metallo-β-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns. Ann Burns Fire Disasters. 2012; 25(2):78-81.
Karlowsky JA, Draghi DC. Jones ME, Thornsherry C, Friedland IR, Saham DF. Surveillance for antimicrobial susceptibility among clinical isolates of P. aeruginosa and Acinetobacter baumannii from hospitalized patients in the United states, 1998 to 2001. Antimicrob Agents Chemother 2003;47:1681-8
Fitzroy A, Orrett MD. Antimicrobial susceptibility survey of P.aeruginosa strains isolated from clinical sources. J Nat Med Assoc 2004;96:1065-9
Bertrand X, Thouverej M, Patry C, Balvay P, Talon D. P. aeruginosa : Antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit. Clin Microbiol Infect 2001;7:706-8
Stratcheunski LS, Russian NPRS Group, Kozlov RS. Antimicrobial resistance patterns among gram -negative bacilli isolated from patients in intensive care units: Results multicentre study in Russia. Clin Microbiol Infect 1998;4:497-507
Patel H, Garala RN. Antibiotics Suspetibility pattern of Pseudomonas aeruginosa isolated at SSG Hospital, Baroda. J Res Med Den Sci. 2014;2(1):84–7.
Pramodhini S, Umadevi S, Seetha KS. Detection of Virulence determinant and its association with drug resistance in clinical isolates of Pseudomonas aeruginosa . Int J Res Med Sci. 2016;4(9):3917–23.
Mundhada S, Sharma A, Ingole K, Sheikh S. Prevalence of Pseudomonas aeruginosa in surgical site infection in tertiary care center. Int J Curr Microbiol App Sci. 2017;6:1202–6.
Biswal I, Arora B, Kasana D, Neetushree. Incidence of Multi drug resistant Pseudomonas aeruginosa isolated from burn patients and environmental teaching Institute. J Clin Diag Res. 2014;8:26–29.

